Norovirus Vaccine Development Advances, Clinical Trials Underway

Norovirus, frequently referred to as the winter vomiting bug, currently lacks an approved vaccine. However, researchers appear to be making strides toward developing an effective immunization. Recruitment for clinical trials is underway for volunteers throughout the southern region. The Nova 301 trial, sponsored by the pharmaceutical firm Moderna, is projected to last approximately two years. This trial is being conducted nationwide, with sites in locations such as Bournemouth, Weymouth, Portsmouth, and Oxfordshire. Alex is among those participating in the trial. He stated: “At 77 years old, despite being fairly fit and healthy, if I got norovirus and there was nothing there to help me, I would be really worried.” Another participant, Dennis, expressed his motivation for joining was an opportunity to “give back to the NHS”. Claire Conlan, a ward sister at the Royal Bournemouth Hospital, commented that a vaccine would be “amazing”. She elaborated: “I have been nursing here for 20 years and have seen some catastrophic winters with patients that have been so unwell, so it would be an absolute miracle to give them that vaccine.” The Nova 301 Trial aims to enroll around 25,000 individuals worldwide to assess whether an experimental mRNA vaccine can safeguard people from symptoms associated with the norovirus stomach bug. Participants will be administered either the experimental vaccine or a placebo injection. Dr Patrick Moore, who serves as the national chief investigator for the Nova 301 trial, stated: “Outbreaks of norovirus have huge consequences, both on our health systems and our economy. If you’re interested in helping us advance healthcare, please do come forward to take part in this innovative trial.” Individuals participating in the Nova 301 Trial must be at least 18 years old, in good health, and free from any current chronic gastrointestinal disease. For updates, BBC Hampshire & Isle of Wight is available on Facebook, X (Twitter), or Instagram. Copyright 2024 BBC. All rights reserved. The BBC does not assume responsibility for the content of external sites. Details on our approach to external linking are provided.